Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT01765582

Public ClinicalTrials.gov record NCT01765582. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Steam (Sequencing Triplet With Avastin and Maintenance): FOLFOXIRI/Bevacizumab Regimens (Concurrent and Sequential) vs. FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer

Study identification

NCT ID
NCT01765582
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
280 participants

Conditions and interventions

Interventions

  • 5-fluorouracil Drug
  • bevacizumab Drug
  • capecitabine Drug
  • folinic acid Drug
  • irinotecan Drug
  • oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2013
Primary completion
Mar 13, 2016
Completion
Mar 13, 2016
Last update posted
Sep 17, 2017

2013 – 2016

United States locations

U.S. sites
45
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
University of South Alabama; Mitchell Cancer Institute Mobile Alabama 36604
Long Beach Memorial Medical Center; Oncology Long Beach California 90806
LAC-USC Medical Center Los Angeles California 90033
USC Norris Cancer Center Los Angeles California 90033
Pacific Cancer Care - Monterey Monterey California 93940
Sacramento Center for Hematolo Sacramento California 95816
Pacific Cancer Care Salinas California 93901
Kaiser Permanente - Franklin Denver Colorado 80205
Yale Cancer Center New Haven Connecticut 06520
Sibley Memorial Hospital Washington D.C. District of Columbia 20016
Florida Cancer Specialists - Fort Myers (Colonial Center Dr) Fort Myers Florida 33905
Florida Cancer Specialist, North Region St. Petersburg Florida 33705
University Cancer & Blood Center, LLC Athens Georgia 30607
Emory University Clinic Atlanta Georgia 30322
Central Georgia Cancer Care PC Macon Georgia 31201
Summit Cancer Care PC Savannah Georgia 31405
Ingalls Memorial Hosp Harvey Illinois 60426
Edward Cancer Center Naperville Naperville Illinois 60540
Edward Cancer Center Plainfield Plainfield Illinois 60585
University of Kentucky Medical Center Lexington Kentucky 40536
Johns Hopkins Univ; Bunting Blaustein Cancer Center Baltimore Maryland 21231
Tufts Medical Center Boston Massachusetts 02111
St. Joseph Mercy Hospital; Cancer Care Center. Ann Arbor Michigan 48106
Karmanos Cancer Institute.. Detroit Michigan 48201
Washington University School of Medicine St Louis Missouri 63110
Southeast Nebraska Cancer Center;; Southeast Nebraska Hematology and Oncology Lincoln Nebraska 68510
Nebraska Methodist Hospital; Cancer Center Omaha Nebraska 68114
Dartmouth Hitchcock Med Center Lebanon New Hampshire 03756
Oncology Hematology Care Inc Cincinnati Ohio 45242
University of Oklahoma; Stephenson Oklahoma Canc Ctr Oklahoma City Oklahoma 73104
Milton S. Hershey Medical Center; Penn State Cancer Inst. Hershey Pennsylvania 17033
Chattanooga Oncology and Hematology Associates, PC Chattanooga Tennessee 37404
West Clinic Germantown Tennessee 38138
Sarah Cannon Cancer Center and Research Institute Nashville Tennessee 37203
UT Southwestern MC at Dallas Dallas Texas 75390-9063
Ctr for Cancer and Blood Disorders Fort Worth Texas 76104
Scott and White Hospital; Cancer Center Temple Texas 76508
Virginia Cancer Institute Richmond Virginia 23226
Seattle Cancer Care Alliance - Evergreen Health Kirkland Washington 98034
Seattle Cancer Care Alliance Seattle Washington 98109
Medical Oncology Associates Spokane Washington 99208
Vince Lombardi Cancer Center Green Bay Wisconsin 54311
Medical College of Wisconsin; Dept Froedtert Clin Can Ctr Milwaukee Wisconsin 53226
Aurora Research Institute Wauwatosa Wisconsin 53226
Cheyenne Oncology & Hematology Associates Cheyenne Wyoming 82001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01765582, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2017 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01765582 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →